Ultrasensitive sers nano-sensors for pancreatic cancer diagnosis and prognosis
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA213718
- Recipient
-
Sanguine Diagnostics & Therapeutics Inc. UEI ECGMLSHGH4X6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Omaha, NE 68106, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R41CA213718?
R41CA213718 was awarded to Sanguine Diagnostics & Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 13, 2016.
How much is award R41CA213718 worth?
$300,000 has been obligated on R41CA213718.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award